recombinant egfr ectodomain (Sino Biological)
Sino Biological is a verified supplier 
Sino Biological manufactures this product 
94
Structured Review
Sino Biological
recombinant egfr ectodomain
Recombinant Egfr Ectodomain, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 23 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+egfr/Human+EGFR+%2F+HER1+%2F+ErbB1+Protein/bio_rxiv__64898__2026__03__19__712941-269-0-6
Average 94 stars, based on 23 article reviews
Recombinant Egfr Ectodomain, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 23 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+human+egfr/Human+EGFR+%2F+HER1+%2F+ErbB1+Protein/bio_rxiv__64898__2026__03__19__712941-269-0-6
Average 94 stars, based on 23 article reviews
recombinant egfr ectodomain - by Bioz Stars,
2026-11
94/100 stars
Images
1) Product Images from "Rhomboid protease RHBDL2 is a calcium-activated suppressor of EGFR signalling in keratinocytes"
Article Title: Rhomboid protease RHBDL2 is a calcium-activated suppressor of EGFR signalling in keratinocytes
Journal: bioRxiv
doi: 10.64898/2026.03.19.712941
Figure Legend Snippet: A. Western blot showing knockdown of endogenous RHBDL2 protein in HaCaT cells by multiple shRNAs (01, 00, 02) compared with wild-type (WT) and vector control (V) cells. B. Statistics of the duplicate proteomics experiments. Numbers of identified and quantified proteins ranked by their topology are shown for each of the SILAC experiments, their overlap and union. Type I membrane proteins (with a signal peptide and a single transmembrane helix), which are potential rhomboid substrates, represent about 25% of the secretome in each case and are shown in pale green. Blue, type II membrane proteins; turquoise, polytopic transmembrane proteins; grey, secreted proteins; black, intracellular proteins. C. Changes in membrane protein abundance in HaCaT keratinocyte secretome induced by RHBDL2 expression. In two independent reverse experiments, WT and R2kd HaCaT cells were isotopically labelled by heavy or light lysine and arginine, the media from both populations were pooled and the lectin-enriched glycoproteins were identified and quantified by MS analysis. The abundance ratios of all transmembrane proteins identified in both experiments (i.e. the overlap of the two datasets) were plotted against each other. Two-fold enrichment was set as a significance threshold (dotted line). Membrane proteins occurring in the grey quadrant showed consistent enrichment in both experiments and represent strong candidates for RHBDL2 substrates. D. HaCaT cells were stably transfected with constructs encoding fluorescent fusions of EGFR (GFP) and RHBDL2 (mCherry) and analysed by confocal microscopy. Scale bar = 10 µm. E. Media from WT, vector control (V) and RHBDL2 knockdown (R2kd) HaCaT and MDA-MB-468 cells was concentrated and probed with an antibody raised against the EGFR ectodomain to detect RHBDL2 dependent shedding at endogenous levels of expression. F. Conditioned media from HaCaT cells were divided equally and one half was subjected to high-speed ultracentrifugation (UC) to remove membranes including exosomes. The supernatant after ultracentrifugation and the untreated medium were immunoblotted using separate primary antibodies raised against the extracellular N-terminal (NT) or the intracellular C-terminal part (CT) of EGFR. Ultracentrifugation selectively depletes the full-length form of EGFR, which is reactive against the C-terminal antibody. G . Contribution of metalloproteases to EGFR shedding. N-terminally Strep-tagged EGFR was expressed in HEK293ET cells alongside HA-tagged RHBDL2 or a catalytically inactive mutant (S187A) and cultivated for 24 hrs in the presence or absence of 10 µM BB94. H. The candidate cleavage sites were identified by mass spectrometry (MS) of the purified ectodomain ( Fig. S1 ). Candidate P1 residues were mutated to proline to produce uncleavable mutants and tested by co-overexpression with the WT or inactive mutant enzyme (S187A) in HEK293ET cells. I. An RHBDL2 dependent C-terminal EGFR fragment (open arrow) can be produced by overexpression of the wild-type enzyme in HaCaT cells, but not the S187T inactive mutant (left). RHBDL2 overexpressing cells were incubated overnight with 10 nM PR-171 (PR), 10 µM lactacystin (LC), 10 µM chloroquine (CQ) or 100 nM bafilomycin A1 (BA1) to determine the fate of the fragment (middle). The fragment can also be observed by overnight treatment with bafilomycin A1 at endogenous levels of RHBDL2 expression (right).
Techniques Used: Western Blot, Knockdown, Plasmid Preparation, Control, Multiplex sample analysis, Membrane, Quantitative Proteomics, Expressing, Stable Transfection, Transfection, Construct, Confocal Microscopy, Mutagenesis, Mass Spectrometry, Purification, Over Expression, Produced, Incubation
Figure Legend Snippet: A-C . HaCaT cell lines were seeded equally and grown to confluent monolayers over 48 h. Cells were lysed on ice in the presence of protease and phosphatase inhibitors and samples were diluted to equal concentrations of total protein. Lysates were then probed for various components of EGFR signalling pathways by western blotting. D. HaCaT cell migration was analysed by time-lapse phase-contrast microscopy over the indicated timeframe. Left panel shows the time sequence of the cell colony outline during spreading of wild-type, R2kd and vector transfected cells. Colony outlines were superimposed from first image to last image. For clarity, outlines corresponding to initial 340 min are shown in 20 min increments. Right panel shows quantification of average distance migrated after 16 h. Asterisks correspond to P values (ns=P > 0.05, *=P ≤ 0.05,**= P ≤ 0.01, ***=P ≤ 0.001 and ****= P ≤ 0.0001). E. Gap-closure assay. WT, R2kd and vector HaCaT cells were grown to confluence around removable silicone inserts. After insert removal, gap closure was observed by time-lapse microscopy over 16 h. The average distance migrated is quantified in the box and whisker plot. F. Quantification of migration of WT-HaCaT, R2kd cells and rescue cells in which shRNA refractory wild type RHBDL2 (R2kd+WT) or its inactive S187T mutant (R2kd+mut) were re-introduced into R2kd cells. RHBDL2 overexpression was induced by 5 µg/mL cumate where indicated. G. Depletion of RHBDL2 potentiates invasion of HaCaT cells into a 3D collagen matrix. Spheroids of HaCaT keratinocytes, wild-type (WT), Vector control (V), RHBDL2 knockdown (R2kd) and rescue cells (R2kd+WT, R2kd+mut) were embedded in collagen and their invasion was measured after 72 h by comparing the total area of invaded cells relative to the area of the cell spheroid at 0 h. Invasion is quantified from 5-8 spheroids in each of 3 replicate experiments (total ≥20). Statistical analyses by Tukey’s multiple comparisons test were performed using Prism software (GraphPad Software Inc.). H. HaCaT cell proliferation rate after 48 h growth in 3D collagen was assayed using the Alamar Blue assay. The level of fluorescence is proportional to the metabolic activity and hence can be used to estimate the number of cells relative to each line. The box and whisker plot is generated from 4 replicate experiments. Statistical analyses by Tukey’s multiple comparisons test were performed using Prism software (GraphPad Software Inc.).
Techniques Used: Western Blot, Migration, Microscopy, Sequencing, Plasmid Preparation, Transfection, Time-lapse Microscopy, Whisker Assay, shRNA, Mutagenesis, Over Expression, Control, Knockdown, Software, Alamar Blue Assay, Fluorescence, Activity Assay, Generated
Figure Legend Snippet: A. Quantification of distance migrated by R2kd cells treated with 1 µM AG1478 compared with untreated WT and R2kd cells. B. Quantification of migration of R2kd cells treated with 10 µM GM6001 or BB94 compared with untreated R2kd cells. C. Distance migrated by R2kd cells incubated with conditioned media from WT cells compared with untreated WT, vector and R2kd cells. D. Distance migrated by WT and R2kd cells treated with recombinant EGFR ectodomain (ED, 1 µg/mL), a cocktail of EGFR ligands (EGFRL; EGF, TGFα and Amphiregulin, 10 ng/ml each) or both. E. Distance migrated by WT cells treated with conditioned media from R2kd cells. Where indicated, conditioned media were obtained from R2kd cells treated overnight with 10 µM BB94 or pre-treated with EGFR ectodomain for 1 hour prior to exchange. F. Cell surface levels of endogenous EGFR and CD138 were analysed in WT (green) and R2kd (magenta) HaCaT cells. Intact cells were stained on ice with EGFR and CD138 antibodies, or with rabbit IgG and secondary antibody as a control (grey). The immunostaining was analysed by flow cytometry. The graph shown is one representative experiment out of three biological replicates. The geometric mean fluorescence was calculated for each experiment using FlowJo software. Statistical analysis was performed using an unpaired t-test. Asterisks correspond to P values (ns=P > 0.05, *=P ≤ 0.05,**= P ≤ 0.01, ***=P ≤ 0.001 and ****= P ≤ 0.0001).
Techniques Used: Migration, Incubation, Plasmid Preparation, Recombinant, Staining, Control, Immunostaining, Flow Cytometry, Fluorescence, Software
Figure Legend Snippet: A. HaCaT cells were incubated overnight in serum free media -/+ 10 µM BB94 and 10 ng/mL EGF or TGFα. The media and lysates were harvested and immunoblotted for EGFR. Shedding was quantified using Li-Cor software to determine signal intensity in the media and is displayed relative to the untreated sample above the media panel. B. HaCaT cells stably expressing EGFR-eGFP and mCherry-RHBDL2 were incubated with the indicated EGFR ligand at 10 ng/mL on ice for 1 h, then washed and returned to 37 °C for 15 min and fixed with 3% PFA. GFP and mCherry fluorescence was imaged using confocal microscopy. Scale bar= 10 µm C. HaCaT cells were incubated overnight in serum free media -/+ 10 µM BB94, 80 µM Dynasore and 10 ng/mL EGF. The media and lysates were harvested and immunoblotted for EGFR. Shedding was quantified using Li-Cor software to determine signal intensity in the media and is displayed relative to the untreated sample above the media panel. D. HaCaT-vector (V) and R2kd cells were incubated in serum-free media -/+ 1 µM ionomycin (IM) for 2 h, media and lysates were harvested and immunoblotted for RHBDL2 substrates. E . Stimulation of RHBDL2-mediated EGFR shedding by calcium ionophore treatment requires extracellular calcium. HaCaT cells were incubated for 2 h in serum free media -/+ ionomycin (1 µM) and EGTA (2 mM), BAPTA (2 mM) or Calcium free PBS. A 40 min pre-treatment with BAPTA-AM (100 µM) was performed prior to washing with PBS and subsequent incubation with calcium containing serum-free medium containing ionomycin (1 µM). F. Live HaCaT cells stably overexpressing EGFR-GFP (green) and mCherry-RHBDL2 (red) were treated with 1 µM ionomycin and imaged at regular intervals for 2 h following treatment at 37 °C. Arrowheads indicate sites of plasma membrane blebbing. Scale bar = 5 µm. G. Activation of PLC promotes EGFR shedding. HaCaT cells were incubated for 2 h in serum free media containing ionomycin or increasing concentrations of m-3M3FBS (left). The media and lysates were harvested and immunoblotted for EGFR. In a second experiment, cells were incubated in the presence or absence of m-3M3FBS, the media and lysates were harvested in buffer containing phosphatase inhibitors and immunoblotted for EGFR, PLCγ and phospho-PLCγ (right). H . HaCaT control (V) and R2kd cells were incubated for 2 h in serum-free media -/+ 100 µM m-3M3FBS then media and lysates were harvested and immunoblotted for EGFR. I . HaCaT cells were treated for 2 h with 80 µM m-3M3FBS in serum-free media -/+ calcium. Media and lysates were harvested and immunoblotted for EGFR. UT, untransfected
Techniques Used: Incubation, Software, Stable Transfection, Expressing, Fluorescence, Confocal Microscopy, Plasmid Preparation, Clinical Proteomics, Membrane, Activation Assay, Control
Figure Legend Snippet: A. RHBDL2 mRNA comparison by qPCR in the Ker-CT and HaCaT cells. Gene expression was normalized to GAPDH and the level of RHBDL2 expression in HaCaT cells was used to normalize RHBDL2 expression in all other cell lines, also in panel F. The mRNA analysis was done from three biological replicates, each in three technical replicates. Error bars show standard deviation. B. and C. Immunoblotting of conditioned medium and lysate after 4 h incubation with 5 mM calcium and 1 µM ionomycin detecting shedding of EGFR in primary NHEK-Ad and immortalized keratinocytes Ker-CT that is inhibited by a RHBDL2 ketoamide inhibitor compound 11 (50 µM) confirming RHBDL2 dependency. Tubulin is was used as a loading control. D. Immunoblotting of conditioned medium after 4 h incubation of Ker-CT keratinocytes with 100 µM PLCγ activator m-3M3FBS in the absence and presence of RHBDL2 inhibitor compound 11 (50 µM). E. Immunoblotting of conditioned medium after 4 h incubation of Ker-CT with thapsigargin (2 µM), bradykinin (10 µM) or 5 mM calcium as a positive control that induces RHBDL2 dependent EGFR shedding. F. RHBDL2 mRNA detection by qPCR in the N/TERT keratinocyte derived RHBDL2 knockout (R2ko) cell lines with comparison to the HaCaT and HaCaT RHBDL2 knockdown (R2kd) cells. The mRNA analysis was done from three biological replicates, each in three technical replicates. Error bars show standard deviation. G. Immunoblotting of conditioned medium and lysate of N/TERT keratinocytes to confirm RHBDL2 dependency of EGFR shedding in these cells and to validate the RHBDL2 KO (CB and CC) generated in N/TERT keratinocytes. Constitutive (48 h) or calcium (5 mM) stimulated (4 h) shedding of EGFR is inhibited by compound 11 (50 µM) in the WT, confirming its RHBDL2 dependence.
Techniques Used: Comparison, Gene Expression, Expressing, Standard Deviation, Western Blot, Incubation, Control, Positive Control, Derivative Assay, Knock-Out, Knockdown, Generated
Figure Legend Snippet: A. Constitutive activity of RHBDL2. Monomeric EGFR (green) is cleaved by RHBDL2 (blue) and the released EGFR ectodomain binds EGFR ligands (yellow) in the pericellular space, titrating down their free pool. Dimeric (activated) EGFR is protected from cleavage by RHBDL2. The remaining membrane and cytosolic domains of EGFR are endocytosed and degraded in the lysosome. B . Protracted elevation of intracellular calcium increases RHBDL2 activity and shedding of EGFR ectodomain about 10-fold, which titrates down extracellular ligand levels and limits surface levels of EGFR. C. Loss of RHBDL2 activity leads to increased EGFR signalling, as there are no EGFR ectodomain decoys released that would titrate down the EGFR ligands.
Techniques Used: Activity Assay, Membrane
Related Articles
Recombinant:Article Title: Covalent N -arylation by the pollutant 1,2-naphthoquinone activates the EGF receptor Article Snippet: Transfections were conducted using polyethylenimine MAX (Polysciences, Inc) according to the manufacturer's instructions. .. Article Title: Peripheral White Blood Cell Subsets in Metastatic Colorectal Cancer Patients Treated with Cetuximab: The Potential Clinical Relevance Article Snippet: .. The concentrations of anti-EGFR IgG autoantibodies in the sera of patients and healthy controls were determined by ELISA using Article Title: Protease cleavable bispecific antibodies and uses thereof Article Snippet: Other cell lines were purchased from ATCC. .. Article Title: Chimeric antigen receptor Article Snippet: .. Five days after the second virus infection, Article Title: SIBP-03, a novel anti-HER3 antibody, exerts antitumor effects and synergizes with EGFR- and HER2-targeted drugs. Article Snippet: HER3 (human epidermal growth factor receptor 3) acts through heterodimerization with EGFR (epidermal growth factor receptor) or HER2 to play an essential role in activating phosphoinositide 3-kinase (PI3K) and AKT signaling—a crucial pathway that promotes tumor cell survival.. HER3 is a promising target for cancer therapy, and several HER3-directed antibodies have already entered into clinical trials.. In this study we characterized a novel anti-HER3 monoclonal antibody, SIBP-03. Article Title: Conditionally activated affibody-based prodrug targeting EGFR demonstrates improved tumour selectivity. Article Snippet: .. Subsequently, Article Title: Biomimetic bispecific antibody-drug conjugates based on albumin binding domain fusing nanobodies targeting EGFR and HER2. Article Snippet: .. The following materials were used: MMAE (HY-15162, MCE), mc-vcPAB-MMAE (HY-15575, MCE), human serum albumin (HSA, A8230, Solarbio, Beijing, China), Incubation:Article Title: Covalent N -arylation by the pollutant 1,2-naphthoquinone activates the EGF receptor Article Snippet: Transfections were conducted using polyethylenimine MAX (Polysciences, Inc) according to the manufacturer's instructions. .. Control:Article Title: Covalent N -arylation by the pollutant 1,2-naphthoquinone activates the EGF receptor Article Snippet: Transfections were conducted using polyethylenimine MAX (Polysciences, Inc) according to the manufacturer's instructions. .. Enzyme-linked Immunosorbent Assay:Article Title: Peripheral White Blood Cell Subsets in Metastatic Colorectal Cancer Patients Treated with Cetuximab: The Potential Clinical Relevance Article Snippet: .. The concentrations of anti-EGFR IgG autoantibodies in the sera of patients and healthy controls were determined by ELISA using Article Title: Biomimetic bispecific antibody-drug conjugates based on albumin binding domain fusing nanobodies targeting EGFR and HER2. Article Snippet: .. The following materials were used: MMAE (HY-15162, MCE), mc-vcPAB-MMAE (HY-15575, MCE), human serum albumin (HSA, A8230, Solarbio, Beijing, China), Virus:Article Title: Chimeric antigen receptor Article Snippet: .. Five days after the second virus infection, Infection:Article Title: Chimeric antigen receptor Article Snippet: .. Five days after the second virus infection, Injection:Article Title: Conditionally activated affibody-based prodrug targeting EGFR demonstrates improved tumour selectivity. Article Snippet: .. Subsequently, Construct:Article Title: Conditionally activated affibody-based prodrug targeting EGFR demonstrates improved tumour selectivity. Article Snippet: .. Subsequently, High Performance Liquid Chromatography:Article Title: Biomimetic bispecific antibody-drug conjugates based on albumin binding domain fusing nanobodies targeting EGFR and HER2. Article Snippet: .. The following materials were used: MMAE (HY-15162, MCE), mc-vcPAB-MMAE (HY-15575, MCE), human serum albumin (HSA, A8230, Solarbio, Beijing, China), CCK-8 Assay:Article Title: Biomimetic bispecific antibody-drug conjugates based on albumin binding domain fusing nanobodies targeting EGFR and HER2. Article Snippet: .. The following materials were used: MMAE (HY-15162, MCE), mc-vcPAB-MMAE (HY-15575, MCE), human serum albumin (HSA, A8230, Solarbio, Beijing, China), |
